[144] Concentrix Corp SEC Filing
Rhea-AI Filing Summary
Form 144 notice for Concentrix Corp (CNXC) reports a proposed sale of 500 restricted shares by the named person through Morgan Stanley Smith Barney, with an aggregate market value of $23,540 and an approximate sale date of 09/30/2025 on NASDAQ. The shares were originally acquired as restricted stock on 06/01/2021 from the issuer. The filer also reported two recent sales by the same person in the past three months: 500 shares sold on 07/30/2025 for $28,955 and 500 shares sold on 08/29/2025 for $25,125. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Filing compliance: The Form 144 includes required details (broker, acquisition date, nature of acquisition, sale amounts) demonstrating procedural compliance
- Seller attestation: The notice contains the seller's representation they do not possess undisclosed material adverse information
Negative
- Insider selling disclosed: The person sold or proposes to sell multiple lots (500 shares proposed; 500 and 500 sold in prior months), which may be noted by investors despite small size
Insights
TL;DR: A small insider sale filing for 500 restricted shares; routine compliance with Rule 144, limited market impact.
The filing documents a proposed sale of 500 restricted shares via Morgan Stanley Smith Barney with stated aggregate market value of $23,540 and an expected sale date of 09/30/2025. The securities were acquired from the issuer on 06/01/2021 and reported as restricted stock. The filing also discloses two recent small sales by the same person in July and August 2025. Given the sizes reported relative to the issuer's outstanding shares, this appears to be administrative insider selling rather than a material disposition that would affect valuation.
TL;DR: The Form 144 shows compliance with disclosure rules and includes the seller's attestation about material nonpublic information.
The document identifies the broker, sale amounts, acquisition date, and purchase nature (restricted stock), and contains the required attestation that the seller is unaware of undisclosed adverse information. It also lists two prior small sales in the preceding three months. From a governance perspective, the filing meets procedural requirements for Rule 144 notices; no governance breach or procedural deficiency is evident in the content provided.